Вы находитесь на странице: 1из 2

DRUG STUDY

SIDE
GENERIC/BR CLASSI MECHANIS SPECIAL DOSAGE
INDICATI EFFECTS/ CONTRAINDICA NURSING
AND FICATI M OF PRECAUTIO AND
ON ON ADVERSE TION RESPONSIBILITY
NAME ACTION N FREQUENCY
REACTION
GENERIC
Anti Control of Lowers blood Contraindicated Do not mix or 10 units SQ o to Assess for symptoms of hypoglycaemia (a
NAME: diabetic hyperglycem glucose by: during episodes of dilute drugs 15 minutes restlessness; tingling in hands, feet, lips,
Insulin Lispro agent ia in patients stimulating hypoglycaemia with other before meal chills; cold sweats; confusion; cool, pale s
Endo:
with type 1 glucose uptake insulin difficulty in concentration; drowsiness; nig
HYPOGLYCEMIA.
and type 2 in skeletal Allergy or trouble sleeping; excessive hunger; head
BRAND NAME: diabetes muscle and fat, hypersensitivity to Use cautiously irritability; nausea; nervousness; unstead
Local:
mellitus inhibiting insulin glargine. for patient with hyperglycemia (confusion, drowsiness; flu
Humalog Lipodystrophy,
hepatic glucose hyperthyroidism skin; fruit-like breath odor; rapid, deep br
pruritus,
production. or polyuria; loss of appetite; unusual thirst)
erythema,
Other actions of hyperthyroidism during therapy.
swelling.
insulin:
inhibition of Use cautiously Monitor body weight periodically. Change
Misc:
lipolysis and on patients with may necessitate changes in insulin dose.
Allergic reactions
proteolysis, renal/hepatic
including
enhanced impairment Lab Test Considerations: Monitor blood gl
ANAPHYLAXIS.
protein 6 hr during therapy, more frequently in ke
synthesis. A and times of stress. A1C may be monitore
rapid-acting 6 mo to determine effectiveness.
insulin with
more rapid Toxicity and Overdose: Overdose is manif
onset and symptoms of hypoglycemia. Mild hypogly
shorter duration be treated by ingestion of oral glucose. S
than human hypoglycemia is a life-threatening emerg
regular insulin; treatment consists of IV glucose, glucago
should be used epinephrine.
with an
intermediate- or
long-acting
insulin.

T: 02 555 7551 , F:02 555 7550, E:info@nhhc.ae, W:www.nhhc.ae, P.O. Box: 129396, Abu Dhabi UAE
your homecare provider of choice
Name of Patient: MOHAMED HUMAID AZIZ AL MANSOORI
Name of Nurse: EZRON KENNETH DURAN
Medical Diagnosis: Psychogenic Psychosis, DM type II, CKD stage III, LV dysfunction, mixed hyperlipidemia
Date: May 03, 2017

T: 02 555 7551 , F:02 555 7550, E:info@nhhc.ae, W:www.nhhc.ae, P.O. Box: 129396, Abu Dhabi UAE
your homecare provider of choice

Вам также может понравиться